U.S. Markets open in 2 hrs 27 mins

Gemini Therapeutics, Inc. (GMTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.1200+0.0700 (+3.41%)
At close: 04:00PM EST
2.1200 0.00 (0.00%)
After hours: 04:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.0850
52 Week Low 31.9600
50-Day Moving Average 32.8882
200-Day Moving Average 36.0123

Share Statistics

Avg Vol (3 month) 31.21M
Avg Vol (10 day) 3268.51k
Shares Outstanding 543.11M
Implied Shares Outstanding 6N/A
Float 819.86M
% Held by Insiders 122.51%
% Held by Institutions 171.93%
Shares Short (Dec 14, 2021) 41.78M
Short Ratio (Dec 14, 2021) 40.65
Short % of Float (Dec 14, 2021) 48.06%
Short % of Shares Outstanding (Dec 14, 2021) 44.14%
Shares Short (prior month Nov 14, 2021) 41.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.42%
Return on Equity (ttm)-103.06%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -60.78M
Net Income Avi to Common (ttm)-68.36M
Diluted EPS (ttm)-2.8500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)150.07M
Total Cash Per Share (mrq)3.48
Total Debt (mrq)6.65M
Total Debt/Equity (mrq)4.72
Current Ratio (mrq)12.23
Book Value Per Share (mrq)3.27

Cash Flow Statement

Operating Cash Flow (ttm)-55.88M
Levered Free Cash Flow (ttm)-32.44M